Multimorbidity, polypharmacy, referrals, and adverse drug events: are we doing things well?

被引：152

作者：

Calderon-Larranaga, Amaia ^{[1
]}

Poblador-Plou, Beatriz ^{[1
]}

Gonzalez-Rubio, Francisca ^{[1
]}

Andres Gimeno-Feliu, Luis ^{[1
]}

Maria Abad-Diez, Jose ^{[1
]}

Prados-Torres, Alexandra ^{[1
]}

机构：

[1] Gen Hosp, Hosp Univ Miguel Servet, Zaragoza 50009, Spain

来源：

BRITISH JOURNAL OF GENERAL PRACTICE | 2012年 / 62卷 / 605期

关键词：

D O I：

10.3399/bjgp12X659295

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

Multimorbidity is associated with polypharmacy and may increase the risk of adverse drug events, which become more likely as more medical specialities are involved in management

引用

页数：2

共 48 条

[21] Prescription Adverse Drug Events System (PrescADE) Based on Ontology and Internet of Things
Nakhla, Zina
Nouira, Kaouther
Ferchichi, Ahmed
COMPUTER JOURNAL, 2019, 62 (06): : 801 - 805
[22] What we may we learn.: Drug-related adverse events?
Aranaz-Andrés, JM
MEDICINA CLINICA, 2006, 126 (03): : 97 - 98
[23] Adverse Drug Events After Hospitalization-Are We Missing the Mark?
Bongiovanni, Tasce
Steinman, Michael A.
JAMA INTERNAL MEDICINE, 2021, 181 (05) : 618 - 619
[24] Using INTERCheck® to Evaluate the Incidence of Adverse Events and Drug-Drug Interactions in Out- and Inpatients Exposed to Polypharmacy
Martocchia, Antonio
Spuntarelli, Valerio
Aiello, Francesco
Meccariello, Anna Laura
Proietta, Maria
Del Porto, Flavia
Di Rosa, Roberta
Salemi, Simonetta
March, Massimiliano Rocchietti
Lagana, Bruno
Martelletti, Paolo
Sesti, Giorgio
DRUGS-REAL WORLD OUTCOMES, 2020, 7 (03) : 243 - 249
[25] Risk of Adverse Drug Events among High Need Children: The Role of Psychotropic Polypharmacy and Neighborhood Context
Thomas, Kathleen C.
Annis, I. E.
Christian, R.
deJong, N. A.
Davis, S. A.
Hughes, P. M.
JOURNAL OF MENTAL HEALTH POLICY AND ECONOMICS, 2022, 25 : S32 - S32
[26] A super-combo-drug test to detect adverse drug events and drug interactions from electronic health records in the era of polypharmacy
Zhu, Anqi
Zeng, Donglin
Shen, Li
Ning, Xia
Li, Lang
Zhang, Pengyue
STATISTICS IN MEDICINE, 2020, 39 (10) : 1458 - 1472
[27] Validating a Trigger Tool for Detecting Adverse Drug Events in Elderly Patients With Multimorbidity (TRIGGER-CHRON)
Toscano Guzman, Maria Dolores
Galvan Banqueri, Mercedes
Jose Otero, Maria
Sanchez Fidalgo, Susana
Font Noguera, Isabel
Perez Guerrero, Maria Concepcion
JOURNAL OF PATIENT SAFETY, 2021, 17 (08) : E976 - E982
[28] Preventing opioid-related adverse drug events: We can do this!
Gurwitz, Jerry H.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2022, 70 (01) : 88 - 89
[29] Association between Polypharmacy and Adverse Events in Patients with Alzheimer's Disease: An Analysis of the Japanese Adverse Drug Event Report Database (JADER)
Otani, Nobuhiro
Kanda, Kanae
Ngatu, Nlandu Roger
Murakami, Akitsu
Yamadori, Yusuke
Hirao, Tomohiro
MEDICINA-LITHUANIA, 2024, 60 (10):
[30] Examining patterns of multimorbidity polypharmacy and risk of adverse drug reactions in chronic obstructive pulmonary disease: a cross-sectional UK Biobank study
Hanlon, Peter
Nicholl, Barbara I.
Jani, Bhautesh Dinesh
McQueenie, Ross
Lee, Duncan
Gallacher, Katie I.
Mair, Frances S.
BMJ OPEN, 2018, 8 (01):

← 1 2 3 4 5 →